New hope for rare blood disorder: ravulizumab trial targets platelet recovery
NCT ID NCT07308574
First seen Jan 05, 2026 · Last updated May 04, 2026 · Updated 23 times
Summary
This study is testing a drug called ravulizumab in people with atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and kidney damage. The main goal is to see if the drug improves platelet counts over 26 weeks. About 20 participants will receive the treatment, and researchers will also check kidney function. Since aHUS often requires ongoing management, this is a disease-control study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBunkyō City, 113-8655, Japan
-
Research Site
NOT_YET_RECRUITINGHirakata-shi, 573-1191, Japan
-
Research Site
RECRUITINGIruma-Gun, 350-0495, Japan
-
Research Site
NOT_YET_RECRUITINGKyoto, 602-8566, Japan
-
Research Site
NOT_YET_RECRUITINGMatsumoto-shi, 390-8621, Japan
-
Research Site
NOT_YET_RECRUITINGMiyazaki, 889-1692, Japan
-
Research Site
RECRUITINGNagoya, 466-8650, Japan
-
Research Site
NOT_YET_RECRUITINGNara, 630-8581, Japan
-
Research Site
NOT_YET_RECRUITINGNerima-ku, 177-8521, Japan
-
Research Site
NOT_YET_RECRUITINGSapporo, 060-8638, Japan
-
Research Site
NOT_YET_RECRUITINGShinjuku-ku, 162-8666, Japan
-
Research Site
RECRUITINGTsu, 514-8507, Japan
Conditions
Explore the condition pages connected to this study.